ANEB
Price
$1.08
Change
-$0.05 (-4.42%)
Updated
Jun 6 closing price
Capitalization
46.3M
100 days until earnings call
BIXT
Price
$0.14
Change
-$0.00 (-0.00%)
Updated
Jun 6 closing price
Capitalization
12.17M
Interact to see
Advertisement

ANEB vs BIXT

Header iconANEB vs BIXT Comparison
Open Charts ANEB vs BIXTBanner chart's image
Anebulo Pharmaceuticals
Price$1.08
Change-$0.05 (-4.42%)
Volume$2.75K
Capitalization46.3M
Bioxytran
Price$0.14
Change-$0.00 (-0.00%)
Volume$96.07K
Capitalization12.17M
ANEB vs BIXT Comparison Chart
Loading...
ANEB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BIXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANEB vs. BIXT commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANEB is a Hold and BIXT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (ANEB: $1.08 vs. BIXT: $0.16)
Brand notoriety: ANEB and BIXT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANEB: 54% vs. BIXT: 42%
Market capitalization -- ANEB: $46.3M vs. BIXT: $12.17M
ANEB [@Biotechnology] is valued at $46.3M. BIXT’s [@Biotechnology] market capitalization is $12.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANEB’s FA Score shows that 0 FA rating(s) are green whileBIXT’s FA Score has 0 green FA rating(s).

  • ANEB’s FA Score: 0 green, 5 red.
  • BIXT’s FA Score: 0 green, 5 red.
According to our system of comparison, both ANEB and BIXT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANEB’s TA Score shows that 4 TA indicator(s) are bullish while BIXT’s TA Score has 6 bullish TA indicator(s).

  • ANEB’s TA Score: 4 bullish, 3 bearish.
  • BIXT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, BIXT is a better buy in the short-term than ANEB.

Price Growth

ANEB (@Biotechnology) experienced а -3.57% price change this week, while BIXT (@Biotechnology) price change was +13.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

ANEB is expected to report earnings on Sep 17, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANEB($46.3M) has a higher market cap than BIXT($12.2M). BIXT YTD gains are higher at: 76.863 vs. ANEB (-35.714). BIXT has higher annual earnings (EBITDA): -2.67M vs. ANEB (-7.43M). ANEB has more cash in the bank: 15M vs. BIXT (34.7K). ANEB (0) and BIXT (0) have equivalent revenues.
ANEBBIXTANEB / BIXT
Capitalization46.3M12.2M380%
EBITDA-7.43M-2.67M278%
Gain YTD-35.71476.863-46%
P/E RatioN/AN/A-
Revenue00-
Total Cash15M34.7K43,228%
Total DebtN/A934K-
FUNDAMENTALS RATINGS
BIXT: Fundamental Ratings
BIXT
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANEBBIXT
RSI
ODDS (%)
N/A
Bullish Trend 12 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
86%
Momentum
ODDS (%)
Bullish Trend 12 days ago
89%
Bullish Trend 12 days ago
82%
MACD
ODDS (%)
Bullish Trend 12 days ago
90%
Bullish Trend 12 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
83%
Bullish Trend 12 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
87%
Bearish Trend 12 days ago
83%
Advances
ODDS (%)
Bullish Trend 21 days ago
83%
Bullish Trend 12 days ago
84%
Declines
ODDS (%)
Bearish Trend 27 days ago
87%
Bearish Trend 26 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 13 days ago
79%
Bullish Trend 12 days ago
86%
Aroon
ODDS (%)
Bullish Trend 12 days ago
88%
Bearish Trend 12 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
ANEB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BIXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

ANEB and

Correlation & Price change

A.I.dvisor tells us that ANEB and ABCZF have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANEB and ABCZF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANEB
1D Price
Change %
ANEB100%
-4.42%
ABCZF - ANEB
31%
Poorly correlated
N/A
ALDX - ANEB
28%
Poorly correlated
+0.91%
SRPT - ANEB
24%
Poorly correlated
-2.92%
RLAY - ANEB
23%
Poorly correlated
+3.51%
IMUC - ANEB
23%
Poorly correlated
-16.68%
More

BIXT and

Correlation & Price change

A.I.dvisor tells us that BIXT and CING have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BIXT and CING's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIXT
1D Price
Change %
BIXT100%
+1.21%
CING - BIXT
26%
Poorly correlated
+8.99%
CYTK - BIXT
22%
Poorly correlated
-0.82%
APLM - BIXT
21%
Poorly correlated
+1.14%
ANEB - BIXT
20%
Poorly correlated
-4.42%
TTNP - BIXT
20%
Poorly correlated
-0.65%
More